相关实验视频
Updated: Jul 16, 2025

05:00
Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
5.2K
作为移植中的生物标志物,供体细胞自由DNA
Tarek Abdulhadi1, Louai Alrata1, Casey Dubrawka2
1Department of Medicine, Division of Nephrology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Pharmacogenomics
|September 21, 2023
概括
早期检测移植排斥是非常重要的. 捐赠者衍生的无细胞DNA (dd-cfDNA) 显示为识别急性排斥的生物标记物有前途,可能改善移植的存活率.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 移植免疫学 移植免疫学
- 分子诊断学 分子诊断
背景情况:
- 急性排斥威胁到合移植功能和长期存活.
- 早期检测可以及时干预,以保存移植器官.
- 来自捐赠者的无细胞DNA (dd-cfDNA) 是移植中的新兴生物标志物.
研究的目的:
- 审查dd-cfDNA在早期检测移植拒绝中的作用.
- 为了比较dd-cfDNA与肌素和供体特异性抗体,用于排斥监测.
- 探索dd-cfDNA在其他器官移植和未来应用中的实用性.
主要方法:
- 对移植中dd-cfDNA的现有研究进行系统审查.
- 对dd-cfDNA,肌素和供体特异性抗体的比较分析.
- 在文献中搜索dd-cfDNA在非脏器官移植中的应用.
主要成果:
- dd-cfDNA显示了急性排斥早期检测的潜力.
- 与肌素和供体特异性抗体的比较凸显了dd-cfDNA的实用性.
- dd-cfDNA也在其他实体器官移植环境中进行研究.
结论:
- dd-cfDNA 是一种有前途的生物标志物,用于对移植排斥的非侵入性监测.
- 需要进一步的研究来确定dd-cfDNA作为标准诊断工具.
- 未来的方向包括优化dd-cfDNA测定和验证其在各种移植场景中的使用.
相关概念视频
Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
Kidney Transplant II: Surgical Procedure
22
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
22

